| Vol. 5.26 – 16 July, 2021 |
| |
|
|
| Using comprehensive lipidomic analyses, the authors showed that FXR activation in mice or humans specifically reduced hepatic levels of mono- and polyunsaturated fatty acids. [Cell Metabolism] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists developed a single-nucleus RNA-seq2 method tailored for the comprehensive analysis of the nuclear transcriptome from frozen tissues, allowing the dissection of all cell types present in the liver, regardless of cell size or cellular fragility. [Nature Communications] |
|
|
|
| Researchers showed that anti-Mesothelin (Msln) immunotoxins killed the Msln-expressing fibroblasts and reduced collagen type I deposition in fibrotic liver, indicating that agents that specifically killed Msln-expressing cells should be a useful treatment for cholestatic fibrosis. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Scientists identified adenosine deaminases acting on RNA 1 (ADAR1), which was a key factor in hepatitis B virus evasion from interferon responses in hepatocytes. [Cellular & Molecular Immunology] |
|
|
|
| Using a combination of well-defined genetically engineered tumor cell lines and canonical small molecule ferroptosis inhibitors, researchers provided unequivocal evidence that sorafenib did not induce ferroptosis in a series of tumor cell lines unlike the cognate system xc− inhibitors sulfasalazine and erastin. [Cell Death & Disease] |
|
|
|
| The authors found that aberrant activation of mTORC1 was likely attributed to the reduction of DEP domain-containing protein 5 in the livers of ethanol-fed mice or alcohol-related liver disease patients. [Cell Death & Disease] |
|
|
|
| Investigators reported the ubiquitin-specific peptidase USP29 as a new regulator of HIF1α and of aerobic glycolysis during the development of Sorafenib resistance in hepatocellular carcinoma. [Oncogenesis] |
|
|
|
| Scientists focused on the regulatory effects of parthenolide, a bioactive component derived from Chrysanthemum parthenium L., against hepatic fibrosis via regulating the crosstalk of toll-like receptor 4 and signal transducer and activator of transcription 3 in activated hepatic stellate cells. [Phytotherapy Research] |
|
|
|
| Researchers investigated whether immunohistochemistry and multiplexing for collagen type (I & III) and elastic fibers and a modified Victoria blue method could be helpful. [Scientific Reports] |
| |
|
|
|
| Scientists review cross-sectional studies on dietary habits of patients with nonalcoholic fatty liver disease and randomized controlled trials on the effects of altering dietary macronutrients on intrahepatic triglyceride. [Nature Reviews Gastroenterology & Hepatology] |
|
|
|
| The authors summarize the recent progress in the understanding of the regulatory role of nuclear receptors in hepatic stellate cells and their potential as drug targets in liver fibrosis. [Expert Review of Gastroenterology & Hepatology] |
|
|
|
|
| Perspectum announced that a new prospective, observational, cohort study called Precision medicine for liver tumours with quantitative magnetic resonance imaging and whole genome sequencing is underway. [Perspectum, Inc.] |
|
|
|
| TransMedics Group, Inc. announced that after review and discussion of TransMedics’ clinical evidence from the OCS Liver PROTECT trial, the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee convened by the US FDA has issued a favorable vote in support of approval of the OCS Liver System. [TransMedics Group, Inc. (BioSpace, Inc.)] |
|
|
|
|
| November 29 – December 1, 2021 Barcelona, Spain |
|
|
|
|
|
| Helmholtz Zentrum München – Munich, Germany |
|
|
|
| Johns Hopkins University School of Medicine – Saint Petersburg, Florida, United States |
|
|
|
| University of Minnesota – Austin, Minnesota, United States |
|
|
|
| University of Southern Denmark – Odense, Denmark |
|
|
|
| German Research Center for Environmental Health – Neuherberg, Germany |
|
|
|
|